Gabapentin
A retrospective review of gabapentin has been described in one abstract presentation (Belman, Milazo, Savatic, & Gabis, 2001). Fifteen children, ages 6 to 17 years, experienced greater than a 50% reduction in migraine frequency and duration. Three children stopped the medication because of adverse effects (dizziness and sleep disturbance) or lack of efficacy. Because this is the only published information regarding gabapentin in children, other studies are needed prior to recommending for migraine prophylaxis.
J Pediatr Health Care. 2007;21(6):392-395. © 2007 Mosby, Inc.
Cite this: Anticonvulsant Use for Prophylaxis of the Pediatric Migraine - Medscape - Nov 01, 2007.
Comments